---
$id: https://graph.org.ai/products/commodity/51111643
$type: Product
source: UNSPSC
code: "51111643"
title: "Ketotrexate"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ketotrexate

**UNSPSC Code**: 51111643
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a folate antagonist with the molecular formula C21H27N7O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 504RN634MM, chemically known as n-(p-((2-(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)ethyl)amino)benzoyl)-l-glutamic acid but generally known as ketotrexate, which bears US NIH Compound Identifier 68691. European Medicines Agency schedules Ketotrexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08378MIG. The term KETOTREXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). KETOTREXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ketotrexate under HS 29335995 and SITC 51576. As of Q4 2014, KETOTREXATE remains the US FDA Preferred Term for this commodity. Ketotrexate bears US NLM identifiers UMLS ID C2697842 and NCI Concept Code C77403. SMILES: O=C1NC([NH]C2NCC(N(C12)C)CCNC1CCC(CC1)C(=O)NC(CCC(=O)O)C(=O)O)N.

